DNA Repair Gene Polymorphisms and Chromosomal Aberrations in Exposed Populations.

DNA repair association study chromosomal aberrations exposure polymorphism

Journal

Frontiers in genetics
ISSN: 1664-8021
Titre abrégé: Front Genet
Pays: Switzerland
ID NLM: 101560621

Informations de publication

Date de publication:
2021
Historique:
received: 07 04 2021
accepted: 30 04 2021
entrez: 5 7 2021
pubmed: 6 7 2021
medline: 6 7 2021
Statut: epublish

Résumé

DNA damage and unrepaired or insufficiently repaired DNA double-strand breaks as well as telomere shortening contribute to the formation of structural chromosomal aberrations (CAs). Non-specific CAs have been used in the monitoring of individuals exposed to potential carcinogenic chemicals and radiation. The frequency of CAs in peripheral blood lymphocytes (PBLs) has been associated with cancer risk and the association has also been found in incident cancer patients. CAs include chromosome-type aberrations (CSAs) and chromatid-type aberrations (CTAs) and their sum CAtot. In the present study, we used data from our published genome-wide association studies (GWASs) and extracted the results for 153 DNA repair genes for 607 persons who had occupational exposure to diverse harmful substances/radiation and/or personal exposure to tobacco smoking. The analyses were conducted using linear and logistic regression models to study the association of DNA repair gene polymorphisms with CAs. Considering an arbitrary cutoff level of 5 × 10

Identifiants

pubmed: 34220964
doi: 10.3389/fgene.2021.691947
pmc: PMC8242355
doi:

Types de publication

Journal Article

Langues

eng

Pagination

691947

Informations de copyright

Copyright © 2021 Niazi, Thomsen, Smolkova, Vodickova, Vodenkova, Kroupa, Vymetalkova, Kazimirova, Barancokova, Volkovova, Staruchova, Hoffmann, Nöthen, Dusinska, Musak, Vodicka, Hemminki and Försti.

Déclaration de conflit d'intérêts

HT was an employee at GeneWerk GmbH, which had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell. 2015 Dec 17;163(7):1641-54
pubmed: 26687355
Nat Rev Cancer. 2004 Mar;4(3):177-83
pubmed: 14993899
Nucleic Acids Res. 2015 Jan;43(Database issue):D670-81
pubmed: 25428374
Annu Rev Immunol. 2011;29:319-50
pubmed: 21219174
Dermatol Clin. 2019 Apr;37(2):229-239
pubmed: 30850045
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Environ Health Perspect. 2004 Jun;112(8):867-71
pubmed: 15175174
Genes Chromosomes Cancer. 2018 Feb;57(2):61-69
pubmed: 29052312
Clin Cancer Res. 2004 May 15;10(10):3317-26
pubmed: 15161685
Br J Haematol. 2012 Mar;156(5):573-87
pubmed: 22233151
Genes Chromosomes Cancer. 2013 Jan;52(1):1-10
pubmed: 22997064
Carcinogenesis. 2010 Jul;31(7):1238-41
pubmed: 20215138
Mutat Res. 2008 Nov 17;657(1):3-7
pubmed: 18801460
Mutat Res. 2009 Feb 10;661(1-2):35-40
pubmed: 19027756
G3 (Bethesda). 2011 Nov;1(6):457-70
pubmed: 22384356
Dev Cell. 2012 Nov 13;23(5):908-17
pubmed: 23153487
Science. 2001 Feb 16;291(5507):1284-9
pubmed: 11181991
Mutagenesis. 2019 Dec 19;34(4):323-330
pubmed: 31586183
Mutat Res Genet Toxicol Environ Mutagen. 2018 Dec;836(Pt A):13-21
pubmed: 30389156
Mutagenesis. 2015 Jul;30(4):557-63
pubmed: 25800034
Nature. 2015 Oct 1;526(7571):82-90
pubmed: 26367797
Nucleic Acids Res. 2012 Jan;40(Database issue):D930-4
pubmed: 22064851
Endocr Relat Cancer. 2017 Sep;24(9):T33-T46
pubmed: 28808044
Carcinogenesis. 2015 Nov;36(11):1299-306
pubmed: 26354780
Mutat Res. 2013 Aug 30;756(1-2):5-13
pubmed: 23707699
Mutat Res. 2005 Sep 4;577(1-2):275-83
pubmed: 15922366
Mutat Res. 2012 Aug 1;736(1-2):130-7
pubmed: 22450146
Genes Chromosomes Cancer. 2015 Mar;54(3):194-6
pubmed: 25428887
Adv Protein Chem Struct Biol. 2019;115:21-67
pubmed: 30798933
Mutat Res. 2004 Sep 3;553(1-2):103-10
pubmed: 15288537
Genes Dev. 2020 Mar 1;34(5-6):285-301
pubmed: 32029453
Science. 2002 Jul 26;297(5581):565-9
pubmed: 12142527
Protein Sci. 2018 Jun;27(6):1018-1037
pubmed: 29664212
Nat Rev Cancer. 2011 Feb;11(2):96-110
pubmed: 21258395
Mutat Res. 2009 Mar-Jun;681(2-3):271-298
pubmed: 19103303
Drugs R D. 2020 Jun;20(2):55-73
pubmed: 32215876
Genome Res. 2012 Sep;22(9):1790-7
pubmed: 22955989
Nat Genet. 2013 Jun;45(6):580-5
pubmed: 23715323
J Biol Chem. 2018 Jul 6;293(27):10500-10501
pubmed: 29853635
Mutat Res. 2000 Aug;463(2):111-72
pubmed: 10913908
Environ Health Perspect. 2005 May;113(5):517-20
pubmed: 15866756
Nature. 2014 Jan 16;505(7483):302-8
pubmed: 24429628
Environ Mol Mutagen. 2019 Jan;60(1):17-28
pubmed: 30368896
Cancers (Basel). 2020 Feb 28;12(3):
pubmed: 32121056
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
IARC Sci Publ. 2004;(157):207-15
pubmed: 15055297
Nature. 2004 Nov 18;432(7015):338-41
pubmed: 15549096
Bioinformatics. 2010 Sep 15;26(18):2336-7
pubmed: 20634204
Mutat Res. 2004 Sep 3;553(1-2):91-102
pubmed: 15288536
Mutat Res. 2008 May 10;641(1-2):36-42
pubmed: 18394656
Nature. 2013 Feb 28;494(7438):492-496
pubmed: 23446422
Environ Mol Mutagen. 2004;44(4):283-92
pubmed: 15470755
Nat Rev Cancer. 2007 Apr;7(4):233-45
pubmed: 17361217
Nat Methods. 2011 Dec 04;9(2):179-81
pubmed: 22138821

Auteurs

Yasmeen Niazi (Y)

Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

Hauke Thomsen (H)

Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
GeneWerk GmbH, Heidelberg, Germany.

Bozena Smolkova (B)

Department of Molecular Oncology, Cancer Research Institute, Biomedical Research Center of the Slovak Academy of Sciences, Bratislava, Slovakia.

Ludmila Vodickova (L)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia.
First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University, Prague, Czechia.
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia.

Sona Vodenkova (S)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia.

Michal Kroupa (M)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia.
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia.

Veronika Vymetalkova (V)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia.
First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University, Prague, Czechia.
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia.

Alena Kazimirova (A)

Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.

Magdalena Barancokova (M)

Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.

Katarina Volkovova (K)

Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.

Marta Staruchova (M)

Department of Biology, Faculty of Medicine, Slovak Medical University, Bratislava, Slovakia.

Per Hoffmann (P)

Institute of Human Genetics, School of Medicine and University Hospital Bonn, University of Bonn, Bonn, Germany.
Division of Medical Genetics, Department of Biomedicine, University of Basel, Basel, Switzerland.

Markus M Nöthen (MM)

Institute of Human Genetics, School of Medicine and University Hospital Bonn, University of Bonn, Bonn, Germany.

Maria Dusinska (M)

Health Effects Laboratory, Department of Environmental Chemistry, NILU-Norwegian Institute for Air Research, Kjeller, Norway.

Ludovit Musak (L)

Jessenius Faculty of Medicine, Biomedical Center Martin, Comenius University in Bratislava, Bratislava, Slovakia.

Pavel Vodicka (P)

Department of Molecular Biology of Cancer, Institute of Experimental Medicine, Czech Academy of Sciences, Prague, Czechia.
First Faculty of Medicine, Institute of Biology and Medical Genetics, Charles University, Prague, Czechia.
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia.

Kari Hemminki (K)

Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Faculty of Medicine and Biomedical Center in Pilsen, Charles University in Prague, Prague, Czecia.
Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.

Asta Försti (A)

Department of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany.
Division of Pediatric Neurooncology, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.

Classifications MeSH